Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AVELUMAB Cause Liver function test increased? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Liver function test increased have been filed in association with AVELUMAB (BAVENCIO). This represents 0.3% of all adverse event reports for AVELUMAB.

9
Reports of Liver function test increased with AVELUMAB
0.3%
of all AVELUMAB reports
0
Deaths
3
Hospitalizations

How Dangerous Is Liver function test increased From AVELUMAB?

Of the 9 reports, 3 (33.3%) required hospitalization, and 1 (11.1%) were considered life-threatening.

Is Liver function test increased Listed in the Official Label?

Yes, Liver function test increased is listed as a known adverse reaction in the official FDA drug label for AVELUMAB.

What Other Side Effects Does AVELUMAB Cause?

Death (361) Disease progression (355) Off label use (200) Diarrhoea (153) Infusion related reaction (142) Pyrexia (129) Fatigue (124) Neoplasm progression (119) Dyspnoea (100) Nausea (99)

What Other Drugs Cause Liver function test increased?

METHOTREXATE (3,839) ADALIMUMAB (2,070) ETANERCEPT (1,829) LEFLUNOMIDE (1,521) ABATACEPT (1,415) TOCILIZUMAB (1,406) RITUXIMAB (1,325) SULFASALAZINE (1,263) HYDROXYCHLOROQUINE (1,259) TOFACITINIB (1,221)

Which AVELUMAB Alternatives Have Lower Liver function test increased Risk?

AVELUMAB vs AVIBACTAM AVELUMAB vs AVIBACTAM\CEFTAZIDIME AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE\TITANIUM DIOXIDE\ZINC AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE AVELUMAB vs AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE

Related Pages

AVELUMAB Full Profile All Liver function test increased Reports All Drugs Causing Liver function test increased AVELUMAB Demographics